ASPHO 2021 - American Society of Pediatric Hematology / Oncology Annual Meeting (Virtual Meeting)
Apr 20 - Apr 23, 2021 | PortlandORUS
LARVOL is not affiliated with American Society of Pediatric Hematology / Oncology Annual Meeting (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 21 abstracts linked to Trials
[VIRTUAL] AZACITIDINE AS EPIGENETIC PRIMING FOR CHEMOTHERAPY IS SAFE IN INFANTS WITH KMT2A-REARRANGED ALL
[VIRTUAL] IBRUTINIB+RICE/RVICI FOR R/R MATURE B-NHL IN CHILDREN/YOUNG ADULTS: SPARKLE TRIAL INTERIM ANALYSIS
[VIRTUAL] A PHASE 1 STUDY OF TALIMOGENE LAHERPAREPVEC (T-VEC) IN PEDIATRIC PATIENTS WITH ADVANCED SOLID TUMORS
[VIRTUAL] ZUMA-4 PHASE 1 LONG-TERM RESULTS: KTE-X19 CAR T-CELL THERAPY IN CHILDREN/ADOLESCENTS WITH R/R B-ALL
[VIRTUAL] First-in-human HA-1 targeting TCR memory T cell immunotherapy for pediatric patients with relapsed hematologic malignancies post allogeneic hematopoietic cell transplantation
[VIRTUAL] Hematopoietic Toxicities and Coagulopathy Following CD22 CAR T-cells
[VIRTUAL] UPDATED RESULTS FROM THE HGB-206 GROUP C STUDY OF LENTIGLOBIN FOR SICKLE CELL DISEASE GENE THERAPY
[VIRTUAL] LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS
[VIRTUAL] SAFETY AND EFFICACY OF DEFERIPRONE VS DEFEROXAMINE FOR TRANSFUSION-DEPENDENT ANEMIAS
[VIRTUAL] BETI-CEL GENE THERAPY OUTCOMES IN PEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA
[VIRTUAL] POST-HSCT OUTCOMES AFTER EMAPALUMAB TREATMENT IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
[VIRTUAL] MYPART RARE TUMOR NETWORK: EARLY RESULTS AND INTERIM ANALYSIS OF CHORDOMA AND ACC PATIENT COHORTS
[VIRTUAL] VIROIMMUNOTHERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMAS
[VIRTUAL] REAL-WORLD EXPERIENCE OF PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE TREATED WITH OXBRYTA®
[VIRTUAL] CROSSING OUR T'S: AN UNUSUAL PRESENTATION OF INFANTILE T-CELL LEUKEMIA